Novem Group’s Tiziana Life Sciences TLSA Stock Holding History

Novem Group’s Portfolio TLSA Stock Details TLSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,000	Closed	-$10.8K	–	438
2025 Q1	$10.8K	Buy	+10,000	New	+$9.77K	﹤0.01%	367

Other funds holding TLSA

DIG

Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Zhang Financial Portage, Michigan $2.89B AUM 18.44% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Novem Group's TLSA Position: Q2 2025 in Review

Novem Group sold out of Tiziana Life Sciences (TLSA) in Q2 2025, closing a stake of 10,000 shares — an estimated $10.8K sold.

Novem Group first reported a position in TLSA in Q1 2025 and held it in 1 quarter. The position peaked at $10.8K in Q1 2025. 30 funds tracked by Wall St. Rank hold TLSA as of Q2 2025.

Novem Group reported no remaining Tiziana Life Sciences position as of Q2 2025 after selling out during the quarter.
Novem Group sold 10,000 Tiziana Life Sciences shares in Q2 2025, an estimated $10.8K.
Novem Group first reported a position in Tiziana Life Sciences in Q1 2025 and held it in 1 quarter.
Novem Group's Tiziana Life Sciences position peaked at $10.8K in Q1 2025.
30 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q2 2025.

Based on Novem Group's 13F filing for Q2 2025, filed 16 Jul 2025.